Vac 60 2025 - Group Leader

The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive **cancer research center** dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth. The IJC is also part of the network of Excellence Research Centers of Catalonia **(CERCA)** and was accredited as a **Severo Ochoa Center of Excellence** by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer **(FCAECC)** Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute **(ISCIII)**. The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has **six locations integrated into reference hospitals**: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings. The Josep Carreras Leukemia Research Institute is looking for a** Group Leader**for our Can Ruti Campus to open a new research line focused on improving the quality of life of hematological cancer patients. **RESEARCH DESCRIPTION** This position is funded by the Severo Ochoa funds associated to the accreditation of excellence (CEX2023-001258-S) by the Ministerio de Ciencia, Innovación y Universidades - Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033). **WHAT WE NEED** - PhD in Psycho-oncology, Health Outcomes Research, Behavioral Medicine, or a related field. - Excellent scientific record and clear research focus on survivorship and quality‑of‑life in patients with hematological malignancies. - Proven track record as Principal Investigator and coordinator on collaborative competitive grants. - Minimum 10 years’ experience in research. - Leadership, team‑building, and communication skills. **WHAT WE OFFER** - Full time temporary contract (“_Indefinido por actividades científico técnicas_”) linked to the implementation of the strategic plan supported by the Severo Ochoa funds associated to the accreditation of excellence. **_ Este contrato es parte de la ayuda #CEX2023-001258-S, financiado por MCIN/AEI/10.13039/501100011033._** - The selected Group Leader will receive a start-up package including personnel funding, dedicated laboratory space, and access to the state-of-the-art Core Facilities at IJC. - Be part of a young, collaborative and international work environment with cutting edge technologies and interdisciplinary teams of scientists, including experts in medicine, immunology, genomics and bioinformatics. - Exciting and innovative research projects covering from cancer genetics and epigenetics, immunogenomics and regulatory genomics, to precision‑medicine studies in transplantation, cell and gene therapy for blood cancers. - The stimulating environment of the Barcelona metropolitan area Catalonia’s BioRegion, ranked 5ᵗʰ in Europe and 8ᵗʰ worldwide for active clinical trials, with >1.700 oncology studies and a pipeline of 75 cancer therapies in development. **DEADLINE** **WHO WE ARE?** **_ What makes us different?_**: The mission of the Josep Carreras Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. The IJC’s vision is to be a world-class reference and excellent research multicampus that contributes to the improvement of results, and the cure of patients affected by leukemia and other malignant hemopathies, through innovation, sustainability, social responsibility, talent, and professional experience. **_ HR Excellence_**: In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities. The IJC’s commitment to these values and principles strengthens our internal